Literature DB >> 16403059

Comparison between anatomical and integrated approaches to atrial fibrillation ablation: adjunctive role of electrical pulmonary vein disconnection.

Roberto Mantovan1, Roberto Verlato, Vittorio Calzolari, Stella Baccillieri, Alessandro De Leo, Pietro Turrini, Giovanni Pastore, Martino Crosato, Angelo Ramondo, Paolo Stritoni.   

Abstract

INTRODUCTION: The aim of this study was to compare the outcome of anatomical pulmonary vein (PV) radiofrequency (RF) ablation with that of an integrated approach (anatomical with electrophysiological confirmation of PV disconnection).
METHODS: Sixty consecutive patients affected by drug-refractory paroxysmal (39), persistent (13), and permanent (8) atrial fibrillation (AF) were assigned to an anatomical (group A: 30 patients; 25 male, 5 female, mean age: 55 +/- 7 years) or integrated approach (group B: 30 patients; 26 male, 4 female, mean age: 52 +/- 9 years). In all cases, RF ablation was performed by means of the Carto system in order to anatomically create circumferential lines around PVs. In group B, the persistence of PV potentials was then assessed with a multipolar circular catheter. If PV potentials persisted, RF pulses targeting the electrophysiological breakthroughs were delivered to disconnect PVs.
RESULTS: Total procedure duration, fluoroscopy time, and RF delivery time were similar in both groups: 227 +/- 43, 50 +/- 23, and 43 +/- 16 minutes (group A); 232 +/- 32, 55 +/- 15, and 42 +/- 10 minutes (group B), respectively (ns). One asymptomatic PV stenosis and one pericardial effusion occurred in group A and B, respectively. After 15.4 +/- 7.4 months, 17 (57%) group A patients and 25 (83%) group B patients were in stable sinus rhythm (P = 0.02) (RR 1.78; 95% CI: 1.7-2.9).
CONCLUSIONS: PV ablation by means of an integrated anatomical and electrophysiological approach seems more effective than a purely anatomical RF ablation approach. Electrophysiological confirmation of PV disconnection could be a useful marker of successful RF treatment of AF.

Entities:  

Mesh:

Year:  2005        PMID: 16403059     DOI: 10.1111/j.1540-8167.2005.00217.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  Long-term single procedure efficacy of catheter ablation of atrial fibrillation.

Authors:  Aamir Cheema; Chandrasekhar R Vasamreddy; Darshan Dalal; Joseph E Marine; Jun Dong; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Sunil Sinha; Henry Halperin; Ronald Berger; Hugh Calkins
Journal:  J Interv Card Electrophysiol       Date:  2006-08-05       Impact factor: 1.900

2.  Accuracy of integration of multislice computed tomography imaging into three-dimensional electroanatomic mapping for real-time guided radiofrequency ablation of left atrial fibrillation-influence of heart rhythm and radiofrequency lesions.

Authors:  Martin Martinek; Hans-Joachim Nesser; Josef Aichinger; Gernot Boehm; Helmut Purerfellner
Journal:  J Interv Card Electrophysiol       Date:  2007-02-23       Impact factor: 1.900

3.  Radiofrequency ablation of paroxysmal atrial fibrillation by mesh catheter.

Authors:  Claudio Pratola; Pasquale Notarstefano; Paolo Artale; Tiziano Toselli; Elisa Baldo; Lina Marcantoni; Chiara Carrescia; Paolo Squasi; Roberto Ferrari
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

4.  Atrial Fibrillation Radiofrequency Ablation: Safety Using Contact Force Catheter In A Low-Volume Centre.

Authors:  Diego Vaccari Md; Daniele Giacopelli MSc; Eros Rocchetto MSc; Sabina Vittadello Md; Roberto Mantovan Md; Gianfilippo Neri Md
Journal:  J Atr Fibrillation       Date:  2014-08-31

5.  MRI-Guided Electrophysiology Intervention.

Authors:  Henry R Halperin; Aravindan Kolandaivelu
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

Review 6.  Cardiovascular magnetic resonance guided electrophysiology studies.

Authors:  Aravindan Kolandaivelu; Albert C Lardo; Henry R Halperin
Journal:  J Cardiovasc Magn Reson       Date:  2009-07-06       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.